NorthWest Biotherapeutics Inc (NWBO)

[H2R]

Ph III Enrollment: "We anticipate that the the recruitment to be complete hopefully by the end of this year [2015] for the recruitment, there is an additional recruitment step after that, but the recruitment is what takes the patients into the trial process and then the primary end point would be next year in the summer.

In terms of the interim analysis, it would be likely to be this year, potentially in the coming months." Minutes 26'10 of the VirtualInvestorConference Webcast.

(Busy time, I finally got back to the Webcast).